Comparison of Reduced-Intensity and Conventional Myeloablative Regimens for Allogeneic Transplantation in Non-Hodgkin’s Lymphoma-Reference-Cited by-同舟云学术

Comparison of Reduced-Intensity and Conventional Myeloablative Regimens for Allogeneic Transplantation in Non-Hodgkin’s Lymphoma

Published:2006-12 Issue:12 Volume:12 Page:1326-1334
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Rodriguez Roberto,Nademanee Auayporn,Ruel Nora,Smith Eileen,Krishnan Amrita,Popplewell Leslie,Zain Jasmine,Patane Kathy,Kogut Neil,Nakamura Ryotaro,Sarkodee-Adoo Clarence,Forman Stephen J.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference22 articles.

1. Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft;Ringden;Bone Marrow Transplant,1999

2. Allogeneic bone marrow transplantation in patients who relapse after autologous transplantation;Tsai;Bone Marrow Transplant,1997

3. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy;Giralt;Blood,1997

4. Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation;Porter;Biol Blood Marrow Transplant,2001

5. National Cancer Institute–sponsored study of classifications of non-Hodgkin’s lymphomas: summary and description of a working formulation for clinical usage;Cancer,1982

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Results of a Phase II Trial of Allogeneic Hematopoietic Stem Cell Transplantation Using 90Y-Ibritumomab Tiuxetan (Zevalin) in Combination With Fludarabine and Melphalan in Patients With High-Risk B-Cell Non-Hodgkin's Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2023-09

2. TCR-α/β and CD19 depleted stem cell grafts from haploidentical donors for allogeneic transplantation in patients with relapsed lymphoma: a single-center experience;Leukemia & Lymphoma;2023-08-10

3. Stem Cell Transplant for T Cell Non-Hodgkin Lymphoma;Basics of Hematopoietic Stem Cell Transplant;2023

4. Long-Term Remission After Matched Sibling Donor Hematopoietic Cell Transplantation in a Patient With Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma;Cureus;2021-05-20

5. Allogeneic hematopoietic cell transplantation using fludarabine plus myeloablative busulfan and melphalan confers promising survival in high-risk hematopoietic neoplasms: a single-center retrospective analysis;Hematology;2021-01-01